Skip to main content
Premium Trial:

Request an Annual Quote

PlexBio Inks Italian Distribution Deals

NEW YORK (360Dx) – Taiwanese firm PlexBio today announced distribution deals for its products in Italy.

PlexBio and Eurclone Diagnostica inked an exclusive distribution contract to market and sell PlexBio's IntelliPlex 1000 πCode Processor, the PlexBio 100 Fluorescent Analyzer, and several PlexBio CE-marked IVD kits for molecular diagnostics in a targeted segment of the Italian IVD clinical market, PlexBio said.

The PlexBio 100 Fluorescent Analyzer received CE marking in August.

Separately, Euroclone, the parent firm of Euroclone Diagnostica, will be the exclusive distributor of the  IntelliPlex 1000 πCode Processor and the PlexBio 100 Fluorescent Analyzer for the Italian life science research market. The deal also provides for the sale by Euroclone of research reagents based on PlexBio's πCode MicroDisc technology and accessories.

Financial and other terms of the agreements were not disclosed.

The deals provide PlexBio a direct sales and support channel in Italy, the firm said.

"Establishing these distribution relations with Euroclone is a critical first step to PlexBio's European market entry strategy and we are very happy that, together with our partners at Euroclone, we will be able to provide an innovative and powerful workflow solution for two key multiplex testing market segments in Italy," PlexBio COO Stuart Palmer said in a statement.

Earlier this year, PlexBio announced an expansion of its collaboration with Denka to include the codevelopment of a molecular diagnostic platform for infectious disease testing.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.